Transition care for adolescents with congenital heart disease
The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease on Transition Readiness, Self-Management Skills and Care Satisfaction
This study tests a new support program to help teenagers with congenital heart disease smoothly transition to adult healthcare and learn how to take care of their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 16 Years to 20 Years |
| Sex | All |
| Sponsor | Ankara Yildirim Beyazıt University Academic / other |
| Locations | 2 sites (Ankara, Ankara Yenimahalle and 1 other locations) |
| Trial ID | NCT06433401 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of a structured transition care model on adolescents with congenital heart disease as they move from pediatric to adult healthcare systems. It aims to enhance their readiness for adult care, improve self-management skills, and raise awareness about the importance of regular medical follow-ups. The intervention includes training materials such as brochures, posters, and slide presentations to support the transition process. The study is designed as a randomized controlled trial to assess the effectiveness of this approach.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 16-20 with a diagnosis of congenital heart disease who have been under follow-up care for at least one year.
Not a fit: Patients who may not benefit from this study include those who cannot communicate in Turkish or have mental disabilities that hinder communication.
Why it matters
Potential benefit: If successful, this study could significantly improve the health outcomes and quality of life for adolescents with congenital heart disease as they transition to adult care.
How similar studies have performed: Other studies have shown success with similar transitional care approaches, indicating potential for positive outcomes in this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntarily agree to participate in the research * To be between the ages of 16-20, * Having a diagnosis of congenital heart disease, * Being followed up with a diagnosis of congenital heart disease for at least one year in the polyclinics where the study was conducted, * To be able to communicate in Turkish, * Not having any mental deficiency that may prevent communication Exclusion Criteria: * Refusing to participate in the research, * Not being able to communicate in Turkish, * Not showing up regularly for follow-ups, * Having any mental disability that may prevent communication
Where this trial is running
Ankara, Ankara Yenimahalle and 1 other locations
- Republic of Turkey Ministry of Health Ankara Etlik City Hospital — Ankara, Ankara Yenimahalle, Turkey (Türkiye) (Not_yet_recruiting)
- Republic of Turkey Ministry of Health Ankara Etlik City Hospital — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Tutku KIRÇI TEMİZ, PhD s. — Ankara Yildirim Beyazıt University
- Study coordinator: Tutku KIRÇI TEMİZ, PhD s.
- Email: tutkukrc29095@gmail.com
- Phone: +905064278982
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.